| Send2Press.com • Today is Wednesday, June 19, 2013 | A Member of the Neotrope News Network |  |
|
|
Send2Press : U.S. and World News :
Medical :
Drugs and Pharmaceuticals
: Ophthalmic Research and Development Company Launches Adjunctive Eyelid Therapy and Hygiene Product
Press Release:
Ophthalmic Research and Development Company Launches Adjunctive Eyelid Therapy and Hygiene Product
RICHMOND, Texas - Aug. 6 (SEND2PRESS NEWSWIRE) -- CYNACON/OCuSOFT(R) (OCuSOFT, Inc.) specializes in ophthalmic research, development and supply to ophthalmologists and optometrists. They are excited to announce a new and innovative prescription-only ALODOX(R) Convenience Kit for adjunctive eyelid therapy and hygiene.  The ALODOX(R) Convenience Kit contains ALODOX(R) (Doxycycline Hyclate 20 milligrams); OCuSOFT(R) Lid Scrub(TM) PLUS Extra Strength Pre-Moistened Pads; and OCuSOFT(R) Lid Scrub(TM) Original Foaming Eyelid Cleanser. This new and convenient combination therapy promises to significantly increase patient compliance while improving overall eyelid-hygiene therapy. OCuSOFT(R) Lid Scrub(TM) PLUS Extra Strength Pre-Moistened Pads is an extra strength eyelid cleanser that uses a low-level preservative and moisturizer blend, offering a wide range of anti-bacterial properties. It is perfect for moderate to severe eyelid conditions. OCuSOFT(R) Lid Scrub(TM) Original Foaming Eyelid Cleanser is an instant foam liquid that generates pre-lathered foam immediately upon depressing the control-tip pump. The foam formula provides patients who are on a lid-hygiene regimen, with added convenience. It is economical and ideal for shower use. So, why combine all three? Reports confirm that ALODOX(R) is prescribed much more often than minocycline, partly because it is a more potent collagenase inhibitor. Therefore, the use of low-dose doxycycline hyclate has demonstrated effective enzyme modulation treatment of inflammatory disease. And, at such low levels - 50 milligrams or less - doxycycline reduces inflammation, yet still maintains maximum plasma drug concentrations below the anti-microbial threshold, resulting in fewer side effects. "We are excited to be able to offer the ALODOX Convenience Kit for systemic inflammatory relief," Patrick Witham, Executive Vice President, CYNACON/OCuSOFT(R), said. "While traditional doxycycline has been prescribed for years, new research suggests that low-dose doxycycline is just as effective, and without the added side effects such as gastritis and photosensitivity." Coupled with OCuSOFT(R) Lid Scrub(TM) products, the ALODOX(R) Convenience Kit has a mission that will lead to increased patient satisfaction and compliance. CYNACON/OCuSOFT(R) (OCuSOFT, Inc.), founded in 1986, is a company dedicated to addressing clinical needs through well-researched and technological solutions. They are dedicated to optimizing the delivery and performance of ophthalmic pharmaceutical products while improving patient care, quality of life, and compliance. For more information on the ALODOX(R) Convenience Kit, visit: www.alodox.com. To learn more about the company and find out about other available products, visit: www.ocusoft.com.
NEWS SOURCE: CYNACON / OCuSOFT (OCuSOFT, Inc.)
Canonical Permalink for This Press Release: http://www.send2press.com/newswire/2007-08-0806-003.shtml
Send2Press® is the originating wire service for this story. Terms of Use. © CYNACON / OCuSOFT (OCuSOFT, Inc.). All trademarks acknowledged.
THE CONTENT OF THE ABOVE PRESS RELEASE WAS PROVIDED BY THE NEWS SOURCE ("CYNACON / OCuSOFT (OCuSOFT, Inc.)"), WHO IS SOLELY RESPONSIBLE FOR ITS ACCURACY. FOR QUESTIONS ABOUT THIS STORY CONTACT THE NEWS SOURCE AND NOT THIS WEBSITE.
Journalist Resources:
Download original press release as issued including media contact information for CYNACON / OCuSOFT (OCuSOFT, Inc.).
Additional News Releases on Similar Topics:
|
Additional Press Releases from CYNACON / OCuSOFT (OCuSOFT, Inc.) :
» Ophthalmic Research and Development Company Launches Adjunctive Eyelid Therapy and Hygiene Product
JOURNALISTS & WRITERS:
Subscribe to Send2Press® Daily News Summary by E-Mail
Follow Send2Press on Social Sites: 
|
||||||||||||||||||||||
View our news channels by industry topics, by U.S. States, or by selected U.S. Cities:
|
Terms of Use and License
This "article format" version of the issued press release is Copr. © 1983-2013 Neotrope/Send2Press. You may freely link to this article version of the press release or may use the release text as the basis for an original article or news posting. If the content is copied verbatim via a scraping or copy/paste method, the news item must be properly "attributed" to Send2Press® Newswire as the originating wire service for this story (may not be posted on ANY site selling/offering marketing services, newswire services, or adult content!). |
DISCLAIMER: the above press release content is believed accurate but not guaranteed, and is based on business news supplied by the source. The noted source is solely responsible for its accuracy. Financial/Stock news may contain forward looking statements. Neotrope/Send2Press (this website) makes no claims of accuracy or suitability for any purpose. Any opinions expressed by representatives of company(s) mentioned in news and profiles are solely those of the person indicated, and do not reflect any opinion or policy of Neotrope® or Send2Press. Your use of any information contained herein is done solely at your own risk, and you are fully responsible for using any information herein, or on sites mentioned or linked to in the article. All trademarks acknowledged.
REFERENCES: Ophthalmic Research and Development Company Launches Adjunctive Eyelid Therapy and Hygiene Product, CYNACON OCuSOFT, ALODOX Convenience Kit, ophthalmic research, development and supply to ophthalmologists and optometrists, OCuSOFT Inc, Original Foaming Eyelid Cleanser, Doxycycline Hyclate, collagenase inhibitor, Patrick Witham, eyelid-hygiene therapy, press release, Aug 6, 2007. |
|
THIS PAGE MEDIA READS (by media and public, as of today): 5308 times (1 today, 3 this week, 16 this month, 179 this year)
Site Design and Content is Copr. © 1983 - 2013 Neotrope® - All rights reserved. Send2Press® is a reg. trademark and service mark of NEOTROPE.
Press Release Writing | About Send2Press | Meet Our Staff | Contact Us | Targeted Press Release Distribution Services | Press Release Writing Help Desk | Legal | Privacy | How-To Articles | RSS Feeds | Journalist Tools | Client eMediaKits | Daily News Desk | Success Stories | Online Newswire Service | Internet Marketing Services | Order PR Services | Terms of Service (TOS)